AIC
HRTX icon

Ameritas Investment Company’s Heron Therapeutics HRTX Stock Holding History

Ameritas Investment Company’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,500
Closed -$24.3K – 1298
2021
Q1 		$24.3K Buy
+1,500
New +$26.7K ﹤0.01% 1214
2020
Q2 		– Sell
-1,000
Closed -$12K – 873
2020
Q1 		$12K Buy
+1,000
New +$18.8K ﹤0.01% 1151

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameritas Investment Company's HRTX Position: Q2 2021 in Review

Ameritas Investment Company sold out of Heron Therapeutics (HRTX) in Q2 2021, closing a stake of 1,500 shares — an estimated $24.3K sold.

Ameritas Investment Company first reported a position in HRTX in Q1 2020 and held it in 2 quarters. The position peaked at $24.3K in Q1 2021. 189 funds tracked by Wall St. Rank hold HRTX as of Q2 2021.

  • Ameritas Investment Company reported no remaining Heron Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 1,500 Heron Therapeutics shares in Q2 2021, an estimated $24.3K.
  • Ameritas Investment Company first reported a position in Heron Therapeutics in Q1 2020 and held it in 2 quarters.
  • Ameritas Investment Company's Heron Therapeutics position peaked at $24.3K in Q1 2021.
  • 189 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.